A new study presented at CROI 2019 explored whether switching to monthly long-acting CAB+RPV is noninferior to continuing current 3-drug oral ART in adults with virologically suppressed HIV-1 infection.
...
A new study presented at CROI 2019 explored whether switching to monthly long-acting CAB+RPV is noninferior to continuing current 3-drug oral ART in adults with virologically suppressed HIV-1 infection.
...
A new study presented at CROI 2019 explored whether switching to monthly long-acting CAB+RPV is noninferior to continuing current 3-drug oral ART in adults with virologically suppressed HIV-1 infection.
...
Certain biomarkers could be used to identify people living with HIV who are at increased risk of developing non-alcoholic fatty liver disease, according to recent research.
Certain biomarkers could be used to identify people living with HIV who are at increased risk of developing non-alcoholic fatty liver disease, according to recent research.
Certain biomarkers could be used to identify people living with HIV who are at increased risk of developing non-alcoholic fatty liver disease, according to recent research.
The authors of a new study aimed to investigate CVD risk in women with history of weight cycling, and whether this risk could be associated with menopausal status or pregnancy history. Preliminary findings...
